Delivering Radiopharmaceuticals from Bench to Patients Reliably & at Scale

Optimizing Alpha & Beta Isotope Supply & Manufacturing to Increase Capacity from Preclinical Studies to Clinical Trials & Prepare for Phase 3 to Commercialization & Scale Radioisotope Therapies to Reality

With billion dollar acquisitions from BMS, Eli Lilly, Sanofi and AstraZeneca validating the commercial opportunity of radiopharmaceutical therapies, clinical programs are accelerating into Phase II/III at unprecedented speed. Yet the infrastructure required to sustain this growth is under immense strain. Isotope demand is outpacing global production; half lives leave no margin for error, and the gap between scientific ambition and operational capability is widening across the industry.

The question isn’t whether the science works. It’s whether you can deliver it.

The 4th TRP Supply Chain & Manufacturing Summit is the only industry meeting dedicated entirely to solving these challenges, bringing together the senior leaders responsible for turning pipelines into real, deliverable therapies.

In 2026, the stakes are higher than ever. As infrastructure struggles to keep pace and competition intensifies, the companies that solve supply, scale, and distribution first will define the future of radiopharmaceutical medicine.

Join the organizations leading the charge or risk being left behind.

 

The venue, the group of industry professionals - presenters, attendees, event moderators were all top-notch. The knowledgeable insight shared by all presenters were very helpful.

Senior Manager, Product Development, Capstone Development Services, 2025 Attendee

Capstone Development Services

Excellent meeting! Very informative and inspiring!

Senior Director, Business Development, C-Ray Therapeutics, 2025 Attendee

C-Ray Therapeutics

Small group on a list of focused topics allows for fruitful discussion. Supply chain is a critical issue for this field right now. There are lots of issues and need for collaboration.

Associate Director, Chair, Radiopharmaceutical Trial Team, Comprehensive Cancer Center, Mayo Clinic, 2025 Speaker

Mayo Clinic

Explore the Full Event Guide

  • Expert Speakers from Astrazeneca, Bayer, Telix Pharmaceuticals & More
  • 10+ Case Studies & Guided Discussions uncovering End to End Insights from Isotope Sourcing to Last Mile Delivery
  • 8+ Hours of Dedicated Networking & Collaborative Discussions with CMC Leaders
  • 2 Hands-on Workshops covering isotope supply and geopolitical considerations
Brochure Cover Templates

What To Expect

60+

Attendees from the Biopharma Industry

16

World-Class Speakers

10+

Hours of Dedicated Collaborative Learning & Networking

2

Hands-On Workshops

Official Partners

Brochure Cover Templates
Quick Download

Attending Companies Include:

Telix Pharmaceuticals - Attending Company at the 4th TRP Supply Chain & Manufacturing Summit
Molecular Partners AG - Attending Company at the 4th TRP Supply Chain & Manufacturing Summit
Imaginab - Attending Company at the 4th TRP Supply Chain & Manufacturing Summit
Cellectar Biosciences Inc. - Attending Company at the 4th TRP Supply Chain & Manufacturing Summit
Bayer - Attending Company at the 4th TRP Supply Chain & Manufacturing Summit
Clarity pharmaceuticals - Attending Company at the 4th TRP Supply Chain & Manufacturing Summit
2 (2)

Explore the Agenda

Preview the only end to end program built around every echelon of the radiopharmaceutical supply chain, from isotope sourcing to last mile delivery, alongside interactive discussions and hands-on workshops across three content-rich days.

6 (2)

Partner With Us

Position your organization as the go-to solution provider by showcasing your technologies, services and expertise to supply chain, operations and CMC leaders shaping the next generation of radiopharmaceutical therapies.

12 (3)

Join Biopharma Experts

Connect with supply chain, CMC, manufacturing and quality executives through collaborative discussions, roundtables and dedicated networking sessions to shape the future of how radiopharmaceutical therapies will be produced, distributed and delivered at scale.